ArticleTranslational psychiatry2025
Machine learning-based differentiation of schizophrenia and bipolar disorder using multiscale fuzzy entropy and relative power from resting-state EEG.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Analysis of postpartum and other depression detection using machine learning and deep learning techniques: a systematic review.Frontiers in artificial intelligence · 2026Pooled it
- A systematic review of EEG-based biomarkers for depression, anxiety, and bipolar disorder: trends in explainable artificial intelligence (XAI).BMC psychiatry · 2025Pooled it
- A multiscale spatio-temporal convolutional attention network for depressive disorder diagnosis via coarse-grained signal reconstruction based on EEG.Scientific reports · 2026Article
- A hybrid SMOTE and Gaussian mixture model based optimized XGBoost framework for bipolar disorder detection.Scientific reports · 2026Article
- Integrating Cortical Source Reconstruction and Adversarial Learning for EEG Classification.Sensors (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Schizophrenia (SZ) and bipolar disorder (BD) pose diagnostic challenges due to overlapping clinical symptoms and genetic factors, often resulting in misdiagnosis and suboptimal treatment outcomes. This study aimed to identify EEG-based biomarkers that can differentiate SZ from BD using multiscale fuzzy entropy (MFE) and relative power (RP) analyses and to evaluate their diagnostic utility using machine learning. EEG data were collected from 65 patients with SZ and 49 patients with BD under resting-state conditions. The MFE and RP were calculated for the bilateral frontal, central, and parietal regions using 30 s EEG segments. For MFE, the band-scale fuzzy entropy (FuzzyEn) was determined across the theta, alpha, beta, and gamma bands based on simulation results demonstrating an inverse relationship between scale factors and frequency components. RP was derived by segmenting the EEG data into 2 s intervals with a 500 ms moving window. A support vector machine (SVM) was used to differentiate between patients with SZ and BD based on band-scale FuzzyEn and RP. The SVM classifier achieved an accuracy of 78.94%, a sensitivity of 81.53%, and a specificity of 75.51%. Patients with SZ showed higher theta-scale FuzzyEn in the right frontal, left central, and bilateral parietal regions; higher alpha-scale FuzzyEn in the right parietal region; and increased theta power in the bilateral frontal, central, and right parietal regions. These differences remained robust after controlling for medication effects. These findings demonstrate the potential of combining MFE, RP, and machine learning to differentiate between SZ and BD, contributing to improved diagnostic precision in psychiatric disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.